ClinicalTrials.gov record
Recruiting Phase 3 Interventional

A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urticaria and Symptomatic Dermographism Inadequately Controlled by H1-antihistamines (EMBARQ - ColdU and SD)

ClinicalTrials.gov ID: NCT07266402

Public ClinicalTrials.gov record NCT07266402. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 9:07 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Parallel-Group Study of Barzolvolimab in Participants With Cold Induced Urticaria and Symptomatic Dermographism (EMBARQ-COLDU and SD)

Study identification

NCT ID
NCT07266402
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Celldex Therapeutics
Industry
Enrollment
240 participants

Conditions and interventions

Interventions

  • Barzolvolimab Drug
  • Matching Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 14, 2026
Primary completion
May 31, 2028
Completion
Sep 30, 2028
Last update posted
May 7, 2026

2026 – 2028

United States locations

U.S. sites
26
U.S. states
16
U.S. cities
25
Facility City State ZIP Site status
Cahaba Dermatology & Skin Health Center, LLC Birmingham Alabama 35244 Recruiting
One of a Kind Clinical Research Center, LLC Scottsdale Arizona 85258 Recruiting
Kern Research, Inc. Bakersfield California 93301 Recruiting
One of a Kind Clinical Research Center Napa California 94558 Recruiting
Allergy & Asthma Consultants Redwood City California 94063 Recruiting
Amicis Research Center Sherman Oaks California 91403 Recruiting
FOMAT - Allergy, Asthma & Immunology Medical Group Ventura California 93003 Recruiting
Direct Helpers Research Center Hialeah Florida 33012 Recruiting
Well Pharma Medical Research, Corp. Miami Florida 33143 Recruiting
Deluxe Health Center, LLC Miami Lakes Florida 33014 Recruiting
GCP, Global Clinical Professionals St. Petersburg Florida 33705 Recruiting
Advanced Clinical Research Institute Tampa Florida 33607 Recruiting
Centricity Research Columbus Dermatology Columbus Georgia 31904 Recruiting
Treasure Valley Medical Research Boise Idaho 83706 Recruiting
Endeavor Health Clinical Trials Center Skokie Illinois 60077 Recruiting
Equity Medical, LLC Bowling Green Kentucky 42104 Recruiting
Advanced ENT and Allergy, PLLC Louisville Kentucky 40207 Recruiting
Johns Hopkins University Baltimore Maryland 21224 Recruiting
Revival Research Institute, LLC Troy Michigan 48084 Recruiting
Equity Medical, LLC New York New York 10023 Recruiting
Markowitz Medical PLLC dba OptiSkin Medical New York New York 10128 Recruiting
University of Cincinnati Cincinnati Ohio 45267 Not yet recruiting
Allergy, Asthma & Clinical Research Center Oklahoma City Oklahoma 73120 Recruiting
Advanced Dermatology and Cosmetic Surgery - Spartanburg Spartanburg South Carolina 29307 Recruiting
RFSA Dermatology San Antonio Texas 78212 Recruiting
Allergy Associates of Utah Sandy City Utah 84093 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 46 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07266402, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 7, 2026 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07266402 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →